Developing and focusing

...a broad, balanced portfolio of products with diversified risk and substantial potential value

Pharmaceutical programmes

Cogane™ is being developed for Parkinson's disease and also has potential as a treatment for neuropsychiatric disorders.

Myogane™ an orally active, neurotrophicfactor inducer for ALS

Phytopharm is currently conducting development of novel pharmaceutical products developing a broad, balanced portfolio tartgeted at specific disease areas with diversified risk and substantial potential value. We are currently focusing on the development of our sapogenin family of compounds of which Cogane™ is in preparation for a Phase II clinical study. In addition, we have preclinical programmes in development for asthma, chronic obstructive pulmonary disease and vascular dementia

...on the advancement of our products while creating value for stakeholders

Hoodia extract
weight management functional food product

Phytopica®
natural, three plant product for canine skin health

Functional foods are foodstuffs that provide health or physiological benefits above their nutritional value and have a health claim on the packaging